collection
https://read.qxmd.com/read/31236694/microvascular-spasm-in-non-st-segment-elevation-myocardial-infarction-without-culprit-lesion-minoca
#1
JOURNAL ARTICLE
Giancarlo Pirozzolo, Andreas Seitz, Anastasios Athanasiadis, Raffi Bekeredjian, Udo Sechtem, Peter Ong
BACKGROUND: Up to 30% of patients with acute coronary syndrome have no culprit lesion. Coronary microvascular spasm is an alternative cause for such a clinical presentation. However, this has rarely been investigated systematically. The aim of our study was to assess the frequency of coronary microvascular spasm in patients with NSTEMI without culprit lesion (MINOCA) by intracoronary acetylcholine testing (ACH-test). METHODS: Between 2014 and 2017, 940 patients with NSTEMI underwent coronary angiography and 125 (13%) had no culprit lesion (< 50% stenosis on visual assessment)...
February 2020: Clinical Research in Cardiology: Official Journal of the German Cardiac Society
https://read.qxmd.com/read/31020202/fleckenstein-s-hypothesis-revisited-excessive-myocardial-calcification-after-prolonged-high-dose-catecholamine-treatment-a-case-report
#2
Juliane Dederer, Florian Custodis, Peter Fries, Michael Böhm
Background: Myocardial calcification after prolonged highly dosed catecholamine treatment has been described experimentally. Here, we demonstrate myocardial calcifications by high-dose catecholamine treatment leading to chronic heart failure in patients. Case summary: A 62-year-old Caucasian woman presented with central pulmonary embolism, developing acute heart failure, and cardiogenic shock. Twenty-six days of high-dose norepinephrine treatment had to be administered to maintain circulation...
December 2018: European Heart Journal. Case Reports
https://read.qxmd.com/read/30995890/cardiotoxicity-due-to-targeted-anticancer-agents-a-growing-challenge
#3
REVIEW
Chintan P Shah, Jan S Moreb
The emergence of various targeted anticancer agents has led us to uncharted territory secondary to their cardiotoxic potential with many burning questions, which in turn has led to the evolution of the cardio-oncology field. These targeted agents differ in their cardiovascular complication (CVC) potential even within the same class and it is very difficult to design screening tests that can predict CVCs. Moreover, there is a need for more research to answer many crucial questions, since these toxicities are unanticipated and can lead to poor overall survival of cancer patients...
January 2019: Therapeutic Advances in Cardiovascular Disease
https://read.qxmd.com/read/31016330/time-for-new-imaging-and-therapeutic-approaches-in-cardiac-amyloidosis
#4
EDITORIAL
Riemer H J A Slart, Andor W J M Glaudemans, Walter Noordzij, Johan Bijzet, Bouke P C Hazenberg, Hans L A Nienhuis
No abstract text is available yet for this article.
April 23, 2019: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/30989593/speckle-tracking-echocardiography-in-cardiac-amyloidosis
#5
REVIEW
Mario Stricagnoli, Matteo Cameli, Eufemia Incampo, Stefano Lunghetti, Sergio Mondillo
Speckle tracking echocardiography is an imaging method, based on analysis of 2D echocardiographic images, that is useful in providing information on tissue deformation in different cardiac diseases. Cardiac amyloidosis is a complex pathological entity that can be confused with other causes responsible for cardiac hypertrophy, and for this reason, it can be misdiagnosed, especially in the early stages. Cardiac magnetic resonance and endomyocardial biopsy are reference methods for specific diagnosis, but their use is limited by a number of factors, both of a logistical and technical nature...
September 2019: Heart Failure Reviews
https://read.qxmd.com/read/30977095/straightening-out-the-wrinkles-in-technetium-99m-labeled-bone-scintigraphy-tracer-assessment-of-cardiac-amyloidosis
#6
EDITORIAL
Gary R Small, Terrence D Ruddy
No abstract text is available yet for this article.
April 11, 2019: Journal of Nuclear Cardiology
https://read.qxmd.com/read/30975646/comparison-of-different-techniques-to-identify-cardiac-involvement-in-immunoglobulin-light-chain-al-amyloidosis
#7
COMPARATIVE STUDY
Mohammed A Aljama, M Hasib Sidiqi, Angela Dispenzieri, Morie A Gertz, Martha Q Lacy, Francis K Buadi, David Dingli, Eli Muchtar, Amie L Fonder, Suzanne R Hayman, Miriam A Hobbs, Wilson I Gonsalves, Rahma M Warsame, Taxiarchis Kourelis, Yi Lisa Hwa, Prashant Kapoor, Nelson Leung, Ronald S Go, Robert A Kyle, S Vincent Rajkumar, Shaji K Kumar
We retrospectively reviewed the utility of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) and transthoracic echocardiogram (TTE) in diagnosing cardiac involvement in patients with biopsy-proven systemic immunoglobulin light chain amyloidosis seen at the Mayo Clinic between 1 January 2006 and 30 December 2015. We analyzed 2 cohorts: patients undergoing endomyocardial biopsy for suspicion of cardiac involvement (cohort 1) and patients who had serum NT-proBNP and comprehensive echocardiographic evaluation at diagnosis (cohort 2)...
April 23, 2019: Blood Advances
https://read.qxmd.com/read/30852913/cardiorenal-syndrome-classification-pathophysiology-diagnosis-and-treatment-strategies-a-scientific-statement-from-the-american-heart-association
#8
JOURNAL ARTICLE
Janani Rangaswami, Vivek Bhalla, John E A Blair, Tara I Chang, Salvatore Costa, Krista L Lentine, Edgar V Lerma, Kenechukwu Mezue, Mark Molitch, Wilfried Mullens, Claudio Ronco, W H Wilson Tang, Peter A McCullough
Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic dysfunction in the other organ. It represents the confluence of heart-kidney interactions across several interfaces. These include the hemodynamic cross-talk between the failing heart and the response of the kidneys and vice versa, as well as alterations in neurohormonal markers and inflammatory molecular signatures characteristic of its clinical phenotypes...
April 16, 2019: Circulation
https://read.qxmd.com/read/30852744/pacemaker-implantation-in-familial-amyloid-polyneuropathy-when-and-for-whom
#9
COMPARATIVE STUDY
James Milner, Rafaela Nicolau Teixeira, Ana Vera Marinho, Nuno Silva, Suzana Calretas, José Ferrão, Emanuel Furtado, Maria João Telo, Miguel Ventura, João Cristóvão, Luís Elvas, Guilherme Mariano Pêgo, Natália António
BACKGROUND: Despite the important role of cardiac pacing in preventing syncope and sudden cardiac death in familial amyloid polyneuropathy (FAP), we lack clear guidelines as to the ideal timing and indications for permanent pacemaker implantation. PURPOSE: The purpose of this study was to evaluate the ideal timing for pacemaker implantation in FAP patients submitted to liver transplantation. METHODS: Retrospective study of 258 FAP patients submitted to liver transplantation between 1992 and 2012...
August 2019: Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing
https://read.qxmd.com/read/30813218/early-characteristics-of-fulminant-myocarditis-vs-non-fulminant-myocarditis-a-meta-analysis
#10
JOURNAL ARTICLE
Zicheng Wang, Yanwei Wang, Haiyan Lin, Shengjie Wang, Xianlei Cai, Da Gao
BACKGROUND: Fulminant myocarditis (FM) is a sub-category myocarditis. Its primary characteristic is a rapidly progressive clinical course that necessitates hemodynamic support. FM can be difficult to predict at the onset of myocarditis. The aim of this meta-analysis was to identify the early characteristics in FM compared to those of non-fulminant myocarditis (NFM). METHODS: We searched the databases of MEDLINE, EMBASE, CENTRAL, for studies comparing FM with acute NFM from January 1, 2000 to June 1, 2018...
February 2019: Medicine (Baltimore)
https://read.qxmd.com/read/30843220/electrocardiographic-findings-in-peripartum-cardiomyopathy
#11
MULTICENTER STUDY
Michael C Honigberg, Uri Elkayam, Navin Rajagopalan, Kalgi Modi, Joan E Briller, Mark H Drazner, Gretchen L Wells, Dennis M McNamara, Michael M Givertz
BACKGROUND: There is limited data on electrocardiographic (ECG) abnormalities and their prognostic significance in women with peripartum cardiomyopathy (PPCM). We sought to characterize ECG findings in PPCM and explore the association of ECG findings with myocardial recovery and clinical outcomes. HYPOTHESIS: We hypothesized that ECG indicators of myocardial remodeling would portend worse systolic function and outcomes. METHODS: Standard 12-lead ECGs were obtained at enrollment in the Investigations of Pregnancy-Associated Cardiomyopathy study and analyzed for 88 women...
May 2019: Clinical Cardiology
https://read.qxmd.com/read/30374729/hemodynamic-support-in-the-early-phase-of-septic-shock-a-review-of-challenges-and-unanswered-questions
#12
REVIEW
Olivier Lesur, Eugénie Delile, Pierre Asfar, Peter Radermacher
BACKGROUND: Improving sepsis support is one of the three pillars of a 2017 resolution according to the World Health Organization (WHO). Septic shock is indeed a burden issue in the intensive care units. Hemodynamic stabilization is a cornerstone element in the bundle of supportive treatments recommended in the Surviving Sepsis Campaign (SSC) consecutive biannual reports. MAIN BODY: The "Pandera's box" of septic shock hemodynamics is an eternal debate, however, with permanent contentious issues...
October 29, 2018: Annals of Intensive Care
https://read.qxmd.com/read/29884661/phaeochromocytoma-found-on-cardiovascular-magnetic-resonance-in-a-patient-presenting-with-acute-myocarditis-an-unusual-association
#13
JOURNAL ARTICLE
Sophia Khattak, Iain Sim, Luke Dancy, Benjamin Whitelaw, Dan Sado
Myocarditis is inflammation of the cardiac muscle. The symptoms, signs and basic investigation findings can mimic that of myocardial infarction. The most common cause is infection (most commonly viral). Cardiovascular magnetic resonance (CMR) is the gold standard non-invasive diagnostic test for potential acute myocarditis as it allows assessment of myocardial oedema and scar. A man aged 25 years was admitted with chest pain, dizziness, headache, palpitations and sweating. His troponin was mildly positive. A CMR was performed which showed mild myocarditis and a right suprarenal mass which was confirmed to be a phaeochromocytoma based on biochemistry and a dedicated imaging workup...
June 8, 2018: BMJ Case Reports
https://read.qxmd.com/read/29550324/native-t1-and-extracellular-volume-in-transthyretin-amyloidosis
#14
JOURNAL ARTICLE
Ana Martinez-Naharro, Tushar Kotecha, Karl Norrington, Michele Boldrini, Tamer Rezk, Candida Quarta, Thomas A Treibel, Carol J Whelan, Daniel S Knight, Peter Kellman, Frederick L Ruberg, Julian D Gillmore, James C Moon, Philip N Hawkins, Marianna Fontana
OBJECTIVES: This study evaluated the prognostic potential of native myocardial T1 in cardiac transthyretin amyloidosis (ATTR) and compared native T1 with extracellular volume (ECV) in terms of diagnostic accuracy and prognosis. BACKGROUND: ATTR is an increasingly recognized cause of heart failure that has an overlapping clinical phenotype with hypertrophic cardiomyopathy (HCM). Native T1 mapping by cardiac magnetic resonance (CMR) is useful for diagnosis in cardiac amyloidosis but its prognostic potential has never been assessed...
March 12, 2018: JACC. Cardiovascular Imaging
https://read.qxmd.com/read/29135289/-what-should-we-know-about-cardiac-amyloidosis-from-clinical-signs-to-treatment
#15
REVIEW
Dóra Földeák, Attila Nemes, Anita Kalapos, Péter Domsik, Árpád Kormányos, László Krenács, Enikő Bagdi, Zita Borbényi
Systemic amyloidosis is a rare disease, in which the heart involvement is rather frequent and determines survival remarkably. Regarding the disease and organ involvement, new diagnostic procedures help to establish the diagnosis and to start the adequate treatment as soon as possible. Cardiac involvement is more likely to be characterised by monoclonal immunglobulin free light chain (AL amyloidosis) type and transthyretin type. In case of AL amyloidosis, heart involvement can lead to serious consequences. Biomarker assessments for cardiac function are important to determine disease severity at the beginning and to measure response to the treatment...
November 2017: Orvosi Hetilap
https://read.qxmd.com/read/28840452/transthyretin-cardiac-amyloidosis
#16
REVIEW
Anit K Mankad, Keyur B Shah
PURPOSE OF REVIEW: Transthyretin (TTR)-related cardiac amyloidosis is a progressive infiltrative cardiomyopathy that mimics hypertensive, hypertrophic heart disease and may go undiagnosed. Transthyretin-derived amyloidosis accounts for 18% of all cases of cardiac amyloidosis. Thus, the study's purpose is to provide a comprehensive review of transthyretin cardiac amyloidosis. RECENT FINDINGS: Wild-type transthyretin (ATTRwt) protein causes cardiac amyloidosis sporadically, with 25 to 36% of the population older than 80 years of age are at risk to develop a slowly progressive, infiltrative amyloid cardiomyopathy secondary to ATTRwt...
August 24, 2017: Current Cardiology Reports
https://read.qxmd.com/read/28844519/functional-cardiac-recovery-and-hematologic-response-to-chemotherapy-in-patients-with-light-chain-amyloidosis-from-the-stanford-university-amyloidosis-registry
#17
JOURNAL ARTICLE
Mirela Tuzovic, Yukari Kobayashi, Matthew Wheeler, Christopher Barrett, Michaela Liedtke, Richard Lafayette, Stanley Schrier, Francois Haddad, Ronald Witteles
Cardiac involvement is common in patients with light-chain (AL) amyloidosis and portends a poor prognosis, although little is known about the changes in cardiac mechanics after chemotherapy. We sought to explore the relation between amyloidosis staging and baseline cardiac mechanics and to investigate short-term changes in cardiac mechanics after chemotherapy. We identified 41 consecutive patients from the Stanford Amyloid Center who had echocardiograms and free light-chain values before and after chemotherapy, along with 40 age- and gender-matched controls...
October 15, 2017: American Journal of Cardiology
https://read.qxmd.com/read/28857614/attitudes-about-when-and-how-to-treat-patients-with-al-amyloidosis-an-international-survey
#18
JOURNAL ARTICLE
Paolo Milani, Morie A Gertz, Giampaolo Merlini, Angela Dispenzieri
The aim of this survey was to describe the treatment decision making of expert physicians in when and how to treat patients with AL amyloidosis. Fifty amyloid expert physicians completed the survey. Autologous stem cell transplant (ASCT) was considered the first line therapy, if medically feasible, by 73% of the physicians. Excluding ASCT, cyclophosphamide-bortezomib-dexamethasone regimen was the preferred strategy by 72%. Depending on organ involvement, the goal for treatment was CR for 27-35% and very good partial response (VGPR) for 65-72%...
December 2017: Amyloid: the International Journal of Experimental and Clinical Investigation
https://read.qxmd.com/read/28912185/restrictive-cardiomyopathy-genetics-pathogenesis-clinical-manifestations-diagnosis-and-therapy
#19
REVIEW
Eli Muchtar, Lori A Blauwet, Morie A Gertz
Restrictive cardiomyopathy (RCM) is characterized by nondilated left or right ventricle with diastolic dysfunction. The restrictive cardiomyopathies are a heterogenous group of myocardial diseases that vary according to pathogenesis, clinical presentation, diagnostic evaluation and criteria, treatment, and prognosis. In this review, an overview of RCMs will be presented followed by a detailed discussion on 3 major causes of RCM, for which tailored interventions are available: cardiac amyloidosis, cardiac sarcoidosis, and cardiac hemochromatosis...
September 15, 2017: Circulation Research
https://read.qxmd.com/read/28652676/utility-of-cardiac-magnetic-resonance-in-recurrent-myocarditis
#20
JOURNAL ARTICLE
Abdullah M Alotaibi, Ahmed Aljizeeri, Mouaz Al-Mallah, Ahmed Alsaileek
We report a 26-year-old man who presented to the emergency department four times within a 4-year period with recurrent myocarditis. His presentations were characterized by chest pain, elevated troponin I, and normal coronary angiography. Endomyocardial biopsy showed nonspecific inflammatory process. Laboratory workup including viral screening and autoimmune markers were negative. Cardiac magnetic resonance imaging showed evidence of recurrent myocarditis with progressive appearance of new areas of myocardial delayed enhancement seen in each admission...
July 2017: Journal of the Saudi Heart Association
label_collection
label_collection
2956
1
2
2017-08-16 19:58:56
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.